Engineering pluripotent stem cells with synthetic biology for regenerative medicine
Medical Review · 25.04.2024 · 4 (2) · 90-109
DOI: 10.1515/mr-2023-0050 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Review, online erschienen am 08.03.2024. Verfasst von Yihuan Mao und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program, National Natural Science Foundation of China, CAS Project for Young Scientists in Basic Research.
Abstract (Originalsprache)
Pluripotent stem cells (PSCs), characterized by self-renewal and capacity of differentiating into three germ layers, are the programmable building blocks of life. PSC-derived cells and multicellular systems, particularly organoids, exhibit great potential for regenerative medicine. However, this field is still in its infancy, partly due to limited strategies to robustly and precisely control stem cell behaviors, which are tightly regulated by inner gene regulatory networks in response to stimuli from the extracellular environment. Synthetic receptors and genetic circuits are powerful tools to customize the cellular sense-and-response process, suggesting their underlying roles in precise control of cell fate decision and function reconstruction. Herein, we review the progress and challenges needed to be overcome in the fields of PSC-based cell therapy and multicellular system generation, respectively. Furthermore, we summarize several well-established synthetic biology tools and their applications in PSC engineering. Finally, we highlight the challenges and perspectives of harnessing synthetic biology to PSC engineering for regenerative medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
- Key Laboratory of Organ Regeneration and Reconstruction, Chinese Academy of Sciences, Beijing, China.
- Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China.
- University of Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: Wei Li
Förderung
- National Key Research and Development Program
- National Natural Science Foundation of China
- CAS Project for Young Scientists in Basic Research
Zitieren
APA
Mao, Y., Wang, S., Yu, J., & Li, W. (2024). Engineering pluripotent stem cells with synthetic biology for regenerative medicine. Medical Review, 4(2), 90-109. https://doi.org/10.1515/mr-2023-0050
Vancouver
Mao Y, Wang S, Yu J, Li W. Engineering pluripotent stem cells with synthetic biology for regenerative medicine. Medical Review. 2024;4(2):90-109. doi:10.1515/mr-2023-0050
BibTeX
@article{Mao2024,
author = {Mao, Yihuan and Wang, Siqi and Yu, Jiazhen and Li, Wei},
title = {Engineering pluripotent stem cells with synthetic biology for regenerative medicine},
journal = {Medical Review},
year = {2024},
volume = {4},
number = {2},
pages = {90--109},
doi = {10.1515/mr-2023-0050}
}
EUVIMED